Literature DB >> 15853859

Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals.

M Kanauchi1, K Kimura, K Kanauchi, Y Saito.   

Abstract

To clarify whether beta-cell function and/or insulin resistance contributes to the shape of plasma glucose curve during an oral glucose tolerance test (OGTT), we investigated 583 Japanese subjects with normal glucose tolerance (NGT, n = 306) or impaired glucose tolerance (IGT, n = 277). Each subject was subdivided into three shapes of plasma glucose curve as follows: monophasic pattern (M type), biphasic pattern (B type) and two peaks (T type). Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index and insulinogenic index were assessed by plasma glucose and insulin concentrations obtained at fasting or during an OGTT. There was a greater proportion of M type in the IGT group (M = 80.9%, B = 15.5% and T = 3.6%), whereas the prevalence of B and T types was much higher in the NGT group (M = 66.6%, B = 26.5% and T = 6.9%). There were significant differences in the proportions of shape types between the NGT and IGT groups (p = 0.0006). Among the NGT category, insulin sensitivity was significantly higher in the B type than in the M type, and beta-cell function adjusted for insulin resistance was significantly higher in the B and T types than in the M type. Among the IGT category, no significant differences were seen among the three shape types with respect to insulin sensitivity, but the beta-cell function adjusted for insulin resistance was significantly lower in the M type than in the B and T types. In conclusion, both impaired insulin secretion and insulin resistance may contribute to the underlying mechanisms of the shape of plasma glucose curve in Japanese subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853859     DOI: 10.1111/j.1368-5031.2005.00422.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  28 in total

1.  The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

Authors:  Heba M Ismail; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

2.  Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.

Authors:  Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch
Journal:  Endocrine       Date:  2016-10-03       Impact factor: 3.633

3.  Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts.

Authors:  Akram Alyass; Peter Almgren; Mikael Akerlund; Jonathan Dushoff; Bo Isomaa; Peter Nilsson; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; David Meyre
Journal:  Diabetologia       Date:  2014-10-08       Impact factor: 10.122

4.  The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.

Authors:  Heba M Ismail; Mario A Cleves; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetes Care       Date:  2020-09-08       Impact factor: 19.112

5.  Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk.

Authors:  Stephanie T Chung; Joon Ha; Anthony U Onuzuruike; Kannan Kasturi; Mirella Galvan-De La Cruz; Brianna A Bingham; Rafeal L Baker; Jean N Utumatwishima; Lilian S Mabundo; Madia Ricks; Arthur S Sherman; Anne E Sumner
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-06       Impact factor: 3.478

6.  Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum.

Authors:  Caroline K Kramer; Chang Ye; Anthony J G Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman; Ravi Retnakaran
Journal:  Diabetologia       Date:  2015-03-12       Impact factor: 10.122

7.  The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.

Authors:  Silva Arslanian; Laure El Ghormli; Joon Young Kim; Fida Bacha; Christine Chan; Heba M Ismail; Lorraine E Levitt Katz; Lynne Levitsky; Jeanie B Tryggestad; Neil H White
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

8.  The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.

Authors:  Joon Young Kim; Sara F Michaliszyn; Alexis Nasr; SoJung Lee; Hala Tfayli; Tamara Hannon; Kara S Hughan; Fida Bacha; Silva Arslanian
Journal:  Diabetes Care       Date:  2016-06-12       Impact factor: 19.112

9.  An epigenomic signature of postprandial hyperglycemia in peripheral blood leukocytes.

Authors:  Sung-Mi Shim; Yoon-Kyung Cho; Eun-Jung Hong; Bok-Ghee Han; Jae-Pil Jeon
Journal:  J Hum Genet       Date:  2015-12-03       Impact factor: 3.172

10.  Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.

Authors:  Adam Hulman; Dorte Vistisen; Charlotte Glümer; Michael Bergman; Daniel R Witte; Kristine Færch
Journal:  Diabetologia       Date:  2017-10-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.